Bank of Montreal’s Alexza Pharmaceuticals Inc ALXA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
Sell
-439
Closed 4547
2016
Q1
$0 Hold
439
﹤0.01% 4572
2015
Q4
$0 Hold
439
﹤0.01% 4590
2015
Q3
$1K Hold
439
﹤0.01% 3942
2015
Q2
$0 Hold
439
﹤0.01% 4271
2015
Q1
$1K Hold
439
﹤0.01% 3924
2014
Q4
$1K Hold
439
﹤0.01% 3974
2014
Q3
$1K Sell
439
-12,187
-97% -$46.5K ﹤0.01% 3982
2014
Q2
$57K Buy
12,626
+191
+2% +$825 ﹤0.01% 3143
2014
Q1
$55K Sell
12,435
-145
-1% -$744 ﹤0.01% 3094
2013
Q4
$59K Buy
12,580
+2,456
+24% +$12.1K ﹤0.01% 2794
2013
Q3
$52K Buy
10,124
+9,685
+2,206% +$45.6K ﹤0.01% 2809
2013
Q2
$2K Buy
+439
New +$1.99K ﹤0.01% 3571

Bank of Montreal's ALXA Position: Q2 2016 in Review

Bank of Montreal sold out of Alexza Pharmaceuticals Inc (ALXA) in Q2 2016, closing a stake of 439 shares.

Bank of Montreal first reported a position in ALXA in Q2 2013 and held it in 12 quarters. The position peaked at $59K in Q4 2013. 0 funds tracked by Wall St. Rank hold ALXA as of Q2 2016.

  • Bank of Montreal reported no remaining Alexza Pharmaceuticals Inc position as of Q2 2016 after selling out during the quarter.
  • Bank of Montreal sold 439 Alexza Pharmaceuticals Inc shares in Q2 2016.
  • Bank of Montreal first reported a position in Alexza Pharmaceuticals Inc in Q2 2013 and held it in 12 quarters.
  • Bank of Montreal's Alexza Pharmaceuticals Inc position peaked at $59K in Q4 2013.
  • 0 funds tracked by Wall St. Rank held Alexza Pharmaceuticals Inc as of Q2 2016.

Based on Bank of Montreal's 13F filing for Q2 2016, filed 25 Jul 2016.